Brainomix
The company will use the funds to expand the U.S. market and advance its AI-driven technology into new areas.
The partners were awarded a grant under the UK–Switzerland Bilateral: Collaborative R&D program to develop an AI-enabled stroke diagnosis and treatment platform.
After pioneering in stroke assessment, the investment will be directed to new therapeutic areas for lung fibrosis and cancer.